Drug ratio-dependent antagonism: a new category of multidrug resistance and strategies for its circumvention.

Methods in molecular biology (Clifton, N.J.)

Volumn 596, Issue , 2010, Pages 291-323

  Harasym, Troy O ^a   Liboiron, Barry D ^a   Mayer, Lawrence D ^a  

^a Celator Pharmaceuticals Corp   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; LIPOSOME;

ANIMAL; CHEMISTRY; DRUG ANTAGONISM; DRUG COMBINATION; DRUG DELIVERY SYSTEM; DRUG POTENTIATION; DRUG RESISTANCE; HUMAN; METABOLISM; MULTIDRUG RESISTANCE; NEOPLASM; PHYSIOLOGY; REVIEW; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL LINE, TUMOR; DRUG ANTAGONISM; DRUG COMBINATIONS; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; HUMANS; LIPOSOMES; NEOPLASMS;

MLCS; MLOWN;

EID: 73949140793     PISSN: None     EISSN: 19406029     Source Type: Journal    
DOI: 10.1007/978-1-60761-416-6_13     Document Type: Review

References (103)